Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02234986 |
| Title | A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | CASI Pharmaceuticals, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| CASI Site 03 | San Francisco | California | 94158 | United States | Details | |
| CASI Site 04 | Aurora | Colorado | 80045 | United States | Details | |
| CASI Site 02 | Boston | Massachusetts | 01003 | United States | Details | |
| Casi Site 01 | New York | New York | 10065 | United States | Details | |
| CASI Site 05 | Dallas | Texas | 75231 | United States | Details |